NSC266519
dc.creator | US National Cancer Institute | en_GB |
dc.date.accessioned | 2006-04-28T15:48:27Z | |
dc.date.available | 2006-04-28T15:48:27Z | |
dc.date.created | 2003-02-01 | en_GB |
dc.date.issued | 2006-04-28T15:48:27Z | |
dc.format.extent | 5263 bytes | |
dc.format.extent | 5039 bytes | |
dc.format.mimetype | chemical/x-cml | |
dc.format.mimetype | chemical/x-cml | |
dc.identifier | NSC266519 | en_GB |
dc.identifier.ichi | C10H15N3O4,11H2-5-1H-2H-13(6(14)12-5)8H-3H2-7H(4H2-15H)9H(16H)10H(8)17H | en_GB |
dc.identifier.inchi | InChI=1S/C10H15N3O4/c11-7-1-2-13(10(17)12-7)6-3-5(4-14)8(15)9(6)16/h1-2,5-6,8-9,14-16H,3-4H2,(H2,11,12,17)/t5-,6-,8-,9+/m0/s1 | |
dc.identifier.inchikey | UAZJPMMKWBPACD-UXXCCHNYSA-N | |
dc.identifier.uri | http://www.dspace.cam.ac.uk/handle/1810/154603 | |
dc.language.iso | en_GB | |
dc.publisher | Unilever Center for Molecular Informatics, Cambridge University | en_GB |
dc.title | NSC266519 | en_GB |
dc.title.alternative | 2(1H)-Pyrimidinone, 4-amino-1-(2, 3-dihydroxy-4-(hydroxymethyl)cyclopentyl)-,(1.alpha.,2.beta., 3.beta.,4.alpha.)- (PM)- (9CI) | en_GB |
dc.type | Chemical Structures | en_GB |